2022
DOI: 10.1016/j.jtauto.2022.100148
|View full text |Cite
|
Sign up to set email alerts
|

Positioning of myositis-specific and associated autoantibody (MSA/MAA) testing in disease criteria and routine diagnostic work-up

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
4
0
3

Year Published

2022
2022
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(7 citation statements)
references
References 77 publications
(133 reference statements)
0
4
0
3
Order By: Relevance
“…Recently, inflammatory myopathy is classified based on these myositis-specific autoantibodies because each group has unique characteristics [ 3 ], and anti-synthetase syndrome is a new concept to be a differentiated nosological disease from DM. [ 4 ] For example, patients with MDA-5 antibody-positive DM (MDA-5-DM) often present with clinically amyopathic DM (CADM), which is frequently complicated by rapidly progressive interstitial lung disease (ILD) and have a bad prognosis [ 5 ]. Alternatively, anti-TIF-1γ antibody-positive DM is closely associated with cancer-associated DM, and patients present with skin rashes, proximal muscle weakness, and dysphagia [ 6 ].…”
Section: Introductionmentioning
confidence: 99%
“…Recently, inflammatory myopathy is classified based on these myositis-specific autoantibodies because each group has unique characteristics [ 3 ], and anti-synthetase syndrome is a new concept to be a differentiated nosological disease from DM. [ 4 ] For example, patients with MDA-5 antibody-positive DM (MDA-5-DM) often present with clinically amyopathic DM (CADM), which is frequently complicated by rapidly progressive interstitial lung disease (ILD) and have a bad prognosis [ 5 ]. Alternatively, anti-TIF-1γ antibody-positive DM is closely associated with cancer-associated DM, and patients present with skin rashes, proximal muscle weakness, and dysphagia [ 6 ].…”
Section: Introductionmentioning
confidence: 99%
“…In addition to MSAs, the literature also describes myositis-associated Abs (MAAs). However, in contrast, MAAs exhibit less disease specificity, as they are found in other systemic autoimmune rheumatic diseases as well and are often associated with conditions of disease overlap [134,229].…”
Section: Myositis-specific Autoantibodies (Msa)mentioning
confidence: 99%
“…В последнее время при данной патологии отмечен взрывной рост числа выявляемых антител, среди которых выделяют миозит-специфические антитела (МС-АТ) и миозит-ассоциированные антитела (МА-АТ) [6][7][8][9]. Существует более 15 специфических антител, участвующих в патогенезе аутоиммунной некротизирующей миопатии [4,[7][8][9]. МА-АТ имеют менее выраженную специфичность и часто обнаруживаются при других системных аутоиммунных ревматических болезнях.…”
Section: диагностика и лечение статин-индуцированной некротизирующей ...unclassified
“…При СИНАМ в крови определяются анти-HMGCR и анти-SRP, хотя они могут и отсутствовать. Соответственно, выделяют три серологических варианта заболевания: анти-HMGCR-позитивный, анти-SRP-позитивный и серонегативный [6,8,9,[16][17][18][19]. Титр анти-HMGCR коррелирует с тяжестью проявлений болезни [16].…”
Section: клиническая картинаunclassified
See 1 more Smart Citation